Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News One in seven patients miss cancer surgery during COVID lockdowns - study Planned cancer surgery was affected by lockdowns regardless of the local COVID-19 rates at that time, with patients in lower income countries at highest risk of missing their surgery.
Posted 11 October 2021 Milestone moment for the region's life science sector as construction on No. 1 Birmingham Health Innovation Campus gets underway Construction of No.1 Birmingham Health Innovation Campus (BHIC) in Selly Oak is underway, marking a major milestone for the region's rapidly growing life sciences sector.
Posted 06 October 2021 One in seven patients miss cancer surgery during COVID lockdowns - study One in seven cancer patients around the world have missed out on potentially life-saving operations during COVID-19 lockdowns, a new study reveals.
Posted 04 October 2021 Higher rates of mutation alone are not to blame for age-related disease, study finds Small mutations accumulating in DNA are unlikely to be fully responsible for the ageing process, finds a new study carried out in collaboration with the University of Birmingham.